...
首页> 外文期刊>Molecules >Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca2+ Current Inhibitors for Hypotensive Agent Discovery
【24h】

Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca2+ Current Inhibitors for Hypotensive Agent Discovery

机译:生物活性天然产物和超强酸化学方法用于铅化合物的鉴定:选择性hCA III和L型Ca2 +电流抑制剂用于降压药发现的案例研究

获取原文

摘要

Dodoneine (Ddn) is one of the active compounds identified from Agelanthus dodoneifolius, which is a medicinal plant used in African pharmacopeia and traditional medicine for the treatment of hypertension. In the context of a scientific program aiming at discovering new hypotensive agents through the original combination of natural product discovery and superacid chemistry diversification, and after evidencing dodoneine’s vasorelaxant effect on rat aorta, superacid modifications allowed us to generate original analogues which showed selective human carbonic anhydrase III (hCA III) and L-type Ca2+ current inhibition. These derivatives can now be considered as new lead compounds for vasorelaxant therapeutics targeting these two proteins. View Full-Text
机译:Dodoneine(Ddn)是从Agelanthus dodoneifolius(一种在非洲药典和传统药物中用于治疗高血压的药用植物)中鉴定的活性化合物之一。在一项旨在通过天然产物发现和超酸化学多样化的原始组合发现新的降压药的科学计划的背景下,并证明了多多宁对大鼠主动脉的血管舒张作用后,超酸的修饰使我们能够产生原始的类似物,从而显示出选择性的人类碳酸酐酶。 III(hCA III)和L型Ca2 +电流抑制。现在可以将这些衍生物视为靶向这两种蛋白质的血管舒张治疗剂的新的先导化合物。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号